Literature DB >> 15814074

Tourette's Syndrome.

Donald L Gilbert1, Tara D Lipps.   

Abstract

Tourette's syndrome is a childhood-onset neuropsychiatric disorder characterized by multiple motor and vocal tics, frequently accompanied by symptoms of obsessiveness and/or compulsiveness, anxiety, and behavioral impulsivity. Treatment of Tourette's syndrome symptoms should be considered when symptoms cause significant functional or social impairment or pain, as occurs with self-injurious tics. Because comorbid psychiatric disorders, particularly attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder often are present, clinicians must work with affected persons and families and prioritize treatment targets based on the specific disorder-related impairment. Treatment with alpha-2 adrenergic agonists may reduce tics and improve ADHD symptoms. Effective treatment of ADHD, even with stimulant medications, in most cases does not exacerbate tics. Treatment with selective serotonin reuptake inhibitors may reduce obsessive-compulsive and anxiety symptoms, secondarily reducing tics. Neuroleptics and atypical antipsychotics may be used for severe tics, but the risk of neurologic side effects and weight gain is significantly higher. Habit reversal treatment shows promise as a nonpharmacologic intervention. Use of deep brain stimulation has produced benefit in three severely affected adults but should still be considered experimental.

Entities:  

Year:  2005        PMID: 15814074     DOI: 10.1007/s11940-005-0014-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  36 in total

1.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases.

Authors:  S E Swedo; H L Leonard; M Garvey; B Mittleman; A J Allen; S Perlmutter; L Lougee; S Dow; J Zamkoff; B K Dubbert
Journal:  Am J Psychiatry       Date:  1998-02       Impact factor: 18.112

2.  Repetitive transcranial magnetic stimulation for Tourette syndrome.

Authors:  A Münchau; B R Bloem; K V Thilo; M R Trimble; J C Rothwell; M M Robertson
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

3.  Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.

Authors:  D L Gilbert; G Sethuraman; L Sine; S Peters; F R Sallee
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

4.  Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.

Authors:  Gary R Gaffney; Paul J Perry; Brian C Lund; Kristine A Bever-Stille; Stephan Arndt; Samuel Kuperman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-03       Impact factor: 8.829

5.  Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

Authors: 
Journal:  JAMA       Date:  2004-10-27       Impact factor: 56.272

6.  Treatment of ADHD in children with tics: a randomized controlled trial.

Authors: 
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

7.  Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.

Authors:  S J Perlmutter; S F Leitman; M A Garvey; S Hamburger; E Feldman; H L Leonard; S E Swedo
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

8.  Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations.

Authors:  Lisa A Snider; Laura D Seligman; Bethany R Ketchen; Sara J Levitt; Lauren R Bates; Marjorie A Garvey; Susan E Swedo
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

9.  Stimulant medications precipitate Tourette's syndrome.

Authors:  T L Lowe; D J Cohen; J Detlor; M W Kremenitzer; B A Shaywitz
Journal:  JAMA       Date:  1982-03-26       Impact factor: 56.272

10.  Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.

Authors:  Donald L Gilbert; J Robert Batterson; Gopalan Sethuraman; Floyd R Sallee
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-02       Impact factor: 8.829

View more
  1 in total

1.  Tourette's Disorder.

Authors:  Gholson J Lyon; David Shprecher; Barbara Coffey; Roger Kurlan
Journal:  Curr Treat Options Neurol       Date:  2010-07       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.